CLINICAL_TRIALS trial_result · 2023-11-09

Clinical Trial Update: The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression [Phase 2]

Phase 2 trial results assessing psilocybin as an adjunctive therapy for treatment-resistant depression have been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: COMPASS Pathways | Conditions: Treatment Resistant Depression | Phase 2 | Status: COMPLETED | Results posted: 2023-11-09